2 terminated, 1 completed, 1 withdrawn. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Terminated 2, Completed 1, Withdrawn 1 |
Follow orvepitant: new trials by email Literature Review of orvepitant trials Research Report on orvepitant
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of the Efficacy and Safety of Orvepitant in Subjects With Pruritus Associated With Atopic Dermatitis Orvepitant, Placebo - Pruritus, Atopic Dermatitis | Phase 2 | Withdrawn | Nerre Therapeutics Ltd. | 2018-05-01 | 2018-05-15 | |
| Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder orvepitant, Placebo - Post-Traumatic Stress Disorder | Phase 2 | Completed | GlaxoSmithKline | 132 | 2009-11-02 | 2017-09-01 |
| A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder orvepitant, Placebo - Depressive Disorder | Phase 2 | Terminated | GlaxoSmithKline | 343 | 2009-03-11 | 2017-10-13 |
| A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed Dose Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder orvepitant, placebo - Depressive Disorder, Major | Phase 2 | Terminated | GlaxoSmithKline | 328 | 2009-03-01 | 2017-09-12 |
Depression (2) · Depressive Disorder (1) · Depressive Disorder, Major (1) · Dermatitis, Atopic (1) · Pruritus (1) · Stress Disorders, Post-Traumatic (1)
GlaxoSmithKline (3) · Nerre Therapeutics Ltd. (1)
United States (3) · Canada (2)